Evidence map›Paper›PMID 40899610›Full record

ReviewVirulence2025

The bittersweet link between glucose metabolism, cellular microenvironment and viral infection.

Xueao Liu, Li Chen, Honglin Niu, Yuhan Chen, Peiyao Chen, Lei Liu, Rui Wu

Abstract readReview
In one paragraph

Review in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xueao LiuJiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
Li ChenJiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
Honglin NiuThe Affiliated First Hospital, Jiamusi University, Jiamusi, Heilongjiang, China.
Yuhan ChenJiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
Peiyao ChenJiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
Lei LiuJiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
Rui WuJiamusi University of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.ORCID 0000-0002-9170-0517

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral particles and proteins released during infection profoundly reshape the cellular microenvironment by disrupting host signaling, triggering inflammation, and modulating immune responses. Glucose metabolism, a critical hub for energy production and biosynthesis, is highly susceptible to viral reprogramming. This review summarizes recent findings showing that diverse viruses, including influenza virus, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and enteroviruses, manipulate glucose metabolic pathways to promote replication and evade immune surveillance. Specifically, viruses modulate glycolytic flux, alter the activity of key metabolic enzymes such as hexokinase (HK) and pyruvate kinase, and interfere with signaling networks like PI3K/Akt/mTOR and AMPK. These metabolic alterations further impact the immune landscape by regulating cytokine production, immune cell activation, and antiviral responses. Our analysis highlights a bidirectional interaction: while viruses hijack host glucose metabolism to favor their survival, metabolic changes also generate host-derived antiviral responses. This review highlights the bidirectional crosstalk between metabolic remodeling and microenvironmental changes during viral infection, underscoring the potential of metabolism-based antiviral strategies. A deeper understanding of these mechanisms may inform the development of more effective and targeted interventions against viral diseases.

Indexed as

Cellular MicroenvironmentGlucoseHost-Pathogen InteractionsVirus DiseasesAnimalsCOVID-19GlycolysisHumansSARS-CoV-2Signal TransductionGlucosecellular microenvironmentGlucose metabolismimmune responsemetabolic reprogrammingviral infection

Identifiers

PMID40899610
PMCPMC12413050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.